AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
International Expansion: Tilray Brands, Village Farms, and Curaleaf Expand Medical Cannabis Reach in Europe, Australia, and Turkey
ByAinvest
Tuesday, Nov 11, 2025 4:07 pm ET1min read
Tilray Brands extends its global medical cannabis footprint with key approvals and launches. The company has established Solana Life Group in Panama and expanded its Tilray Craft portfolio in Germany. Tilray Medical also entered a strategic partnership with Italy's L. Molteni & C. dei F.lli Alitti Società di Esercizio S.p.A. to broaden the availability of Tilray Medical cannabis extracts for patients across Italy. Village Farms International retained its position as one of Canada's top three cannabis players, with strong performance in international medical export sales, and Curaleaf Holdings continues to expand its international business with a license to operate in Turkey and the launch of Curaleaf-branded products in Australia.
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet